Get started
Author

Xiaoyang Qi

OpenAlex ID: A5134028608
Reviewer #3 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies
2026 · Yi Lin, Benjamin Liou, et al.
Author response: Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies
2026 · Yi Lin, Benjamin Liou, et al.
Reviewer #2 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies
2026 · Yi Lin, Benjamin Liou, et al.
Reviewer #1 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies
2026 · Yi Lin, Benjamin Liou, et al.
Author response: Patient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease
2026 · Yi Lin, Benjamin Liou, et al.
Reviewer #3 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease
2026 · Yi Lin, Benjamin Liou, et al.
Reviewer #2 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease
2026 · Yi Lin, Benjamin Liou, et al.
Reviewer #1 (Public review): Patient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease
2026 · Yi Lin, Benjamin Liou, et al.
Works count: 8
Citation count:
H-index:
I10-index:
Year
Topic
Type